DB12992InvestigationalSmall molecule
Bleomycin A6 (also known as boanmycin) has been used in trials studying the treatment of Squamous Cell Lung Cancer. It was developed in China as an antineoplastic antibiotic. This drug... It was shown that besides the antitumor effect, Bleomycin A6 had the ability to alter the tumor microenvironment and could contribute toward lung cancer relapse and metastasis on long-term treatment.
- Formula / weight
- C60H96N20O21S2 · 1497.67 g/mol (avg)
- Also known as
- Boanmycin · Pingyangmycin A6 · Zhengguangmycin A6
Resolves to
Structure
InChIKey
FOUFFVYWFNBHHH-YNGSZULRSA-NSMILES[H][C@]1(O[C@H]2[C@@H](O)[C@H](O)[C@H](CO)O[C@H]2O[C@H]([C@H](NC(=O)C2=NC(=NC(N)=C2C)[C@H](CC(N)=O)NC[C@H](N)C(N)=O)C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC2=NC(=CS2)C2=NC(=CS2)C(=O)NCCCNCCCCNCCCN)C2=CN=CN2)O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1OWhat you can answer from here — as of April 02, 2025
Which companies are running trials of Bleomycin A6, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account